Structural Insight into the Mechanism of Dibenzo[a,l]pyrene and Benzo[a]pyrene-Mediated Cell Proliferation Using Molecular Docking Simulations
- 136 Downloads
In the proposed work, we have explicated the mechanism of dibenzo[a,l]pyrene (DBP) and benzo[a]pyrene (BP) modulated cell proliferation by assessing the plausible binding with CASPASES, BAX, Bcl-2, MDM2, p53, p21, p16, CylinD1-CDK4 complex, CylinE1-CDK2 complex, H-Ras, K-Ras, BRCA1, and BRCA2 through exploiting the inherent potential of AutoDock Tools 4.0. In silico findings revealed that potent carcinogenic metabolites of DBP (e.g., (−)-anti-DBPDE and (+)-syn-DBPDE) and BP (e.g., (+)-anti-BPDE) exhibited better binding interactions to Caspase-9 than Caspase-8 and Caspase-3. Feeble interactions of BAX and Bcl-2 with diol-epoxides of both PAHs were observed. Diol-epoxides of DBP and BP were found to bind to p53 with tighter interaction than MDM2 and p53-MDM2 complex. The p16 and Cyclin-CDK complexes were best docked to aforesaid metabolites as compared to p21. Moreover, stronger interactions of BRCA1 and BRCA2 with DBP and feeble interactions of BRCA1 and BRCA2 with BP were observed from docking results. Furthermore, stronger interactions of both DBP and BP with the H-Ras and K-Ras oncoproteins were found, while only DBP interacted relatively strongly with the BRCA1 and BRCA2, which were suggesting more carcinogenic nature of DBP than BP, a well-known observation in the wet lab. Besides giving structural insight into the mechanism of DBP and BP-mediated cell proliferation, these in silico findings may be helpful to understand the mechanistic nature of environmental carcinogens and their cellular targets.
KeywordsDibenzo[a,l]pyrene Benzo[a]pyrene Bcl-2 BAX p53 MDM2 H-Ras Docking
Authors are grateful to the Hon’ble Vice Chancellor of the Integral University for providing the infrastructural facilities to carry out this research (IU/R&D/2016-MCN0001). The partial financial assistance was granted by the Biotechnology Research Trust Fund (BRTF), Integral University, Lucknow.
Compliance with ethical standards
Conflict of interest
The authors would like to declare that there is no conflict of interest.
- 17.Chipuk JE, Bhat M, Hsing AY, Ma J, Danielpour D (2001) Bcl-xL blocks transforming growth factor-β1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J Biol Chem 276:26614–26621CrossRefGoogle Scholar
- 27.Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, Mark E, Wain JC, Kelsey KT (1995) Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomark Prev 4:543–548Google Scholar
- 39.Brooks BR, Brooks CL 3rd, Mackerell AD Jr, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M (2009) CHARMM: the biomolecule simulation program. J Comput Chem 30:1545–1614CrossRefGoogle Scholar
- 44.Baig MH, Sudhakar DR, Kalaiarasan P, Subbarao N, Wadhawa G, Lohani M, Khan MKA, Khan AU (2014). Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: A Molecular Dynamics study. PLOS One 9(12):e112456. doi: 10.1371/journal.pone CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Sharma N, Akhtar S, Jamal QM, Kamal MA, Khan MK, Siddiqui MH, Sayeed U (2016) Elucidation of antiangiogenic potential of Vitexin obtained from Cucumis sativus targeting Hsp90 protein: a novel multipathway targeted approach to restrain angiogenic phenomena. Med Chem 13. doi: 10.2174/1573406413666161111152720 CrossRefGoogle Scholar
- 49.Khan MKA, Siddiqui MH, Akhtar S, Ahmad K, Baig MH, Osama K (2015) Screening of plant-derived natural compounds as potent chemotherapeutic agents against breast cancer: an in silico approach. J Chem Pharm Res 7(1):519–526Google Scholar
- 50.Al-Khodairy FM., Khan MKA, Kunhi M, Pulicat MS, Arif JM (2013) Erysolin induces apoptosis in human breast cancer cell lines: Evidences from in vitro and in silico studies. Am J Bioinform Res 3(3):62–71Google Scholar
- 53.Schelwies K, Sturm I, Grabowski P, Scherubl H, Schindler I, Hermann S Stein H, Huhr HJ, Riecken EO, Zeitz M, Dorken B, Daniel PT (2002) Analysis of P53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors. Int J Cancer 99:589–596CrossRefGoogle Scholar
- 54.Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D (2007) Increased BAX/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 21:123–132PubMedGoogle Scholar